PKI - PerkinElmer, Inc.

NYSE - NYSE Delayed price. Currency in USD
103.08
+0.67 (+0.65%)
At close: 4:03PM EDT

103.08 0.00 (0.00%)
After hours: 4:53PM EDT

Stock chart is not supported by your current browser
Previous close102.41
Open102.35
Bid103.12 x 1400
Ask103.22 x 800
Day's range102.17 - 104.00
52-week range62.91 - 105.70
Volume999,301
Avg. volume916,890
Market cap11.482B
Beta (5Y monthly)1.36
PE ratio (TTM)51.08
EPS (TTM)2.02
Earnings date27 Jul 2020 - 31 Jul 2020
Forward dividend & yield0.28 (0.27%)
Ex-dividend date16 Jul 2020
1y target est101.25
  • PerkinElmer's Tie-Up to Boost Health Outcomes in Africa
    Zacks

    PerkinElmer's Tie-Up to Boost Health Outcomes in Africa

    PerkinElmer's (PKI) partnership with ASH likely to boost newborn screening in underserved populations for better health outcomes in Africa.

  • Why Is PerkinElmer (PKI) Up 11.4% Since Last Earnings Report?
    Zacks

    Why Is PerkinElmer (PKI) Up 11.4% Since Last Earnings Report?

    PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Why You Should Retain PerkinElmer (PKI) in Your Portfolio
    Zacks

    Why You Should Retain PerkinElmer (PKI) in Your Portfolio

    PerkinElmer (PKI) continues to gain traction from strong international presence and robust product portfolio.

  • PerkinElmer to Present at Jefferies Global Healthcare Conference
    Business Wire

    PerkinElmer to Present at Jefferies Global Healthcare Conference

    PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the (virtual) Jefferies Global Healthcare Conference on Thursday, June 4, 2020 at 9:00 a.m. ET.

  • Official Statement from PerkinElmer in Response to Reuters Article Published on May 18, 2020
    Business Wire

    Official Statement from PerkinElmer in Response to Reuters Article Published on May 18, 2020

    PerkinElmer, Inc. (NYSE: PKI) supports government efforts to identify and prevent abusive practices in healthcare. PerkinElmer has received subpoenas from the government regarding investigations into third parties, and has fully cooperated with authorities and will continue to do so. The Company is not aware of, and has not received any information regarding, wrongdoing by PerkinElmer, as implied by Reuters, nor does PerkinElmer have any information that the Company or any of our personnel are the target of a government investigation.

  • PerkinElmer (PKI) Q1 Earnings and Revenues Surpass Estimates
    Zacks

    PerkinElmer (PKI) Q1 Earnings and Revenues Surpass Estimates

    PerkinElmer's (PKI) first-quarter results benefit from growth in Discover & Analytics Solutions segment. However, forex remains a woe.

  • PerkinElmer Inc (PKI) Q1 2020 Earnings Call Transcript
    Motley Fool

    PerkinElmer Inc (PKI) Q1 2020 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2020 PerkinElmer Earnings Conference Call. With me on the call are Prahlad Singh, President and Chief Executive Officer; and Jamey Mock, Senior Vice President and Chief Financial Officer. Statements or comments made on this call may be forward-looking statements, which may include, but are not necessarily limited to, financial projections or other statements of the company's plans, objectives, expectations or intentions.

  • PerkinElmer (PKI) Q1 Earnings and Revenues Beat Estimates
    Zacks

    PerkinElmer (PKI) Q1 Earnings and Revenues Beat Estimates

    PerkinElmer (PKI) delivered earnings and revenue surprises of 42.55% and 1.75%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

  • PerkinElmer Announces Financial Results for the First Quarter of 2020
    Business Wire

    PerkinElmer Announces Financial Results for the First Quarter of 2020

    PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the first quarter ended April 5, 2020.

  • FDA Provides Emergency Use Authorization to PerkinElmer for Serological Test to Identify COVID-19 Antibodies
    Business Wire

    FDA Provides Emergency Use Authorization to PerkinElmer for Serological Test to Identify COVID-19 Antibodies

    PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company) Anti-SARS-CoV-2 ELISA (IgG) serology test. Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA for the detection of antibodies of the immunoglobulin class G.

  • PerkinElmer to Present at BofA Securities Virtual Healthcare Conference 2020
    Business Wire

    PerkinElmer to Present at BofA Securities Virtual Healthcare Conference 2020

    PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the annual BofA Securities Virtual Healthcare Conference 2020 on Thursday, May 14, 2020 at 8:20 a.m. ET.

  • PerkinElmer Board Declares Quarterly Dividend
    Business Wire

    PerkinElmer Board Declares Quarterly Dividend

    The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on April 30, 2020. This dividend is payable on August 7, 2020 to all shareholders of record at the close of business on July 17, 2020.

  • Do Its Financials Have Any Role To Play In Driving PerkinElmer, Inc.'s (NYSE:PKI) Stock Up Recently?
    Simply Wall St.

    Do Its Financials Have Any Role To Play In Driving PerkinElmer, Inc.'s (NYSE:PKI) Stock Up Recently?

    PerkinElmer (NYSE:PKI) has had a great run on the share market with its stock up by a significant 18% over the last...

  • Notice of Change of Location of Annual Meeting of Shareholders of PerkinElmer to Be Held on April 28, 2020
    Business Wire

    Notice of Change of Location of Annual Meeting of Shareholders of PerkinElmer to Be Held on April 28, 2020

    PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, gave notice today that in response to continued public health restrictions on in-person gatherings given the coronavirus/COVID-19 pandemic, the Board of Directors of PerkinElmer has determined to change the format of the company’s Annual Meeting of Shareholders scheduled for Tuesday, April 28, 2020, at 8:00 a.m. EST from in-person to virtual-only. The meeting will be webcast and can be accessed by stockholders at www.virtualshareholdermeeting.com/PKI2020 using the 16-digit control number on their proxy card, voting instruction form or Notice of Internet Availability. The company has designed the format of the Annual Meeting to ensure that shareholders are afforded the same rights and opportunities to participate as they would at an in-person meeting, using online tools to ensure shareholder access and participation. For additional information regarding accessing and participating in the virtual meeting, please refer to the company’s supplemental proxy materials filed with the Securities and Exchange Commission on April 14, 2020.

  • PerkinElmer to Hold Earnings Call on Tuesday, May 5, 2020
    Business Wire

    PerkinElmer to Hold Earnings Call on Tuesday, May 5, 2020

    PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that on Tuesday, May 5, 2020, after market close, the Company will release first quarter 2020 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Jamey Mock, senior vice president and chief financial officer, will host the conference call.

  • FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing
    Business Wire

    FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing

    PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company’s New Coronavirus RT-PCR test. Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this kit to detect SARS-CoV-2, the virus that causes COVID-19. PerkinElmer’s RT-PCR test is marketed as an in vitro diagnostic (IVD) device by meeting the requirements of the European In Vitro Diagnostic Directive (IVDD) and is available in over 30 countries worldwide.

  • What Is PerkinElmer's (NYSE:PKI) P/E Ratio After Its Share Price Tanked?
    Simply Wall St.

    What Is PerkinElmer's (NYSE:PKI) P/E Ratio After Its Share Price Tanked?

    To the annoyance of some shareholders, PerkinElmer (NYSE:PKI) shares are down a considerable 30% in the last month...

  • PerkinElmer First Quarter 2020 Financial Performance Update
    Business Wire

    PerkinElmer First Quarter 2020 Financial Performance Update

    PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it expects first quarter 2020 revenue and earnings per share, both on a GAAP and non-GAAP basis, to be below the Company’s previously communicated guidance.

  • What Is PerkinElmer, Inc.'s (NYSE:PKI) Share Price Doing?
    Simply Wall St.

    What Is PerkinElmer, Inc.'s (NYSE:PKI) Share Price Doing?

    PerkinElmer, Inc. (NYSE:PKI), which is in the life sciences business, and is based in United States, saw significant...

  • PerkinElmer Elects Michel Vounatsos to its Board of Directors
    Business Wire

    PerkinElmer Elects Michel Vounatsos to its Board of Directors

    PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that Michel Vounatsos has been elected to its board of directors, effective March 1, 2020.

  • PerkinElmer, Inc.'s (NYSE:PKI) Earnings Dropped -3.6%, Did Its Industry Show Weakness Too?
    Simply Wall St.

    PerkinElmer, Inc.'s (NYSE:PKI) Earnings Dropped -3.6%, Did Its Industry Show Weakness Too?

    Analyzing PerkinElmer, Inc.'s (NYSE:PKI) track record of past performance is a valuable exercise for investors. It...

  • PerkinElmer (PKI) Q4 Earnings and Revenues Beat Estimates
    Zacks

    PerkinElmer (PKI) Q4 Earnings and Revenues Beat Estimates

    PerkinElmer's (PKI) Q4 earnings benefits from higher revenues and growth in DAS and Diagnostics segments. However, forex remains a woe.

  • PerkinElmer (PKI) Tops Q4 Earnings and Revenue Estimates
    Zacks

    PerkinElmer (PKI) Tops Q4 Earnings and Revenue Estimates

    PerkinElmer (PKI) delivered earnings and revenue surprises of 2.27% and 0.44%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

  • PerkinElmer (PKI) to Report Q4 Earnings: What's in the Cards?
    Zacks

    PerkinElmer (PKI) to Report Q4 Earnings: What's in the Cards?

    Top-line growth and robust performance at Diagnostics segment are likely to have aided PerkinElmer's (PKI) Q4 earnings. However, forex is likely to have remained a woe.